Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
RESEARCH TOOLSreports
Holding SYRE?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -69.01M | $ -38.84M | $ -47.77M | $ -47.75M | $ -33.24M |
| EBITDA | $ -69.01M | $ -38.84M | $ -47.77M | $ -47.75M | $ -33.24M |
| Net Income Common Stockholders | $ -69.03M | $ -38.84M | $ -43.86M | $ -63.18M | $ -40.11M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 414.23M | $ 426.00M | $ 484.64M | $ 339.28M | $ 203.60M |
| Total Assets | $ 421.09M | $ 436.07M | $ 487.60M | $ 341.86M | $ 207.26M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -414.23M | $ -426.00M | $ -484.64M | $ -339.28M | $ -203.60M |
| Total Liabilities | $ 93.70M | $ 51.11M | $ 335.33M | $ 73.29M | $ 65.56M |
| Stockholders Equity | $ 327.39M | $ 364.99M | $ 152.27M | $ 184.02M | $ -245.40M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -29.42M | $ -62.25M | $ -28.54M | $ -31.04M | $ -34.60M |
| Operating Cash Flow | $ -29.42M | $ -62.25M | $ -28.54M | $ -31.04M | $ -34.60M |
| Investing Cash Flow | $ 42.74M | $ -120.52M | $ -104.96M | $ -35.27M | $ -97.63M |
| Financing Cash Flow | $ 12.78M | $ 360.00K | $ 172.16M | $ 163.61M | $ -12.53M |